The Commission also considers that the preparation of Weizmannia faecalis DSM 32016 still satisfies the conditions provided for in Article 5 of Regulation (EC) No 1831/2003, when modifying the terms of the authorisation laid down in Implementing Regulation (EU) 2020/1755, by specifying the compatibility of use of that preparation with the coccidiostats monensin sodium, robenidine hydrochloride, salinomycin sodium and a combination of monensin sodium with nicarbazin, in addition to halofuginone and diclazuril. In addition, considering that those coccidiostats may not be authorised as feed additives for each of the species or categories listed in Implementing Regulation (EU) 2020/1755, their simultaneous use with the preparation of Weizmannia faecalis DSM 32016 should only be possible in accordance with their respective conditions of authorisation as feed additives. Furthermore, the Commission considers that the taxonomic identification of the strain contained in the preparation authorised by Implementing Regulation (EU) 2020/1755 should be updated, as well as the provision on appropriate protective measures to prevent adverse effects on the health of the users of the additive.
Recital 8, Regulation (EU) 2024/1054
In forcesince 10 Apr 2024